Comment on

• Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

  Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Klein EA, Kristal AR. Brasky TM, et al. J Natl Cancer Inst. 2013 Aug 7;105(15):1132-41. doi: 10.1093/jnci/djt174. Epub 2013 Jul 10. J Natl Cancer Inst. 2013. PMID: 23843441 Free PMC article. Clinical Trial.
• RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

  El-Bayoumy K, Thompson H, Manni A. El-Bayoumy K, et al. J Natl Cancer Inst. 2014 Apr;106(4):dju017. doi: 10.1093/jnci/dju017. Epub 2014 Mar 31. J Natl Cancer Inst. 2014. PMID: 24685921 No abstract available.
• RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

  Brenna JT, Burdge GC, Crawford MA, Clayton P, Cunnane SC, Gow R, Hibbeln JR, Sinclair AJ, Stein J, Willatts P. Brenna JT, et al. J Natl Cancer Inst. 2014 Apr;106(4):dju015. doi: 10.1093/jnci/dju015. Epub 2014 Mar 31. J Natl Cancer Inst. 2014. PMID: 24685922 Free PMC article. No abstract available.
• RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial.

  Suburu J, Lim K, Calviello G, Chen YQ. Suburu J, et al. J Natl Cancer Inst. 2014 Apr;106(4):dju023. doi: 10.1093/jnci/dju023. Epub 2014 Mar 31. J Natl Cancer Inst. 2014. PMID: 24685923 Free PMC article. No abstract available.
• RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial.

  McCulloch M, Alvarez E, Gendreau R, Haney S, Harrelson J, Luo R. McCulloch M, et al. J Natl Cancer Inst. 2014 Apr;106(4):dju024. doi: 10.1093/jnci/dju024. Epub 2014 Mar 31. J Natl Cancer Inst. 2014. PMID: 24685926 No abstract available.
• RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

  Harris WS, Davidson MH. Harris WS, et al. J Natl Cancer Inst. 2014 Apr;106(4):dju019. doi: 10.1093/jnci/dju019. Epub 2014 Mar 31. J Natl Cancer Inst. 2014. PMID: 24685928 No abstract available.
• RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

  Torfadottir JE, Stampfer MJ, Mucci LA, Giovannucci EL. Torfadottir JE, et al. J Natl Cancer Inst. 2014 Apr;106(4):dju018. doi: 10.1093/jnci/dju018. Epub 2014 Mar 31. J Natl Cancer Inst. 2014. PMID: 24685929 No abstract available.
• RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

  McCarty MF, Dinicolantonio JJ, Lavie CJ, O'Keefe JH. McCarty MF, et al. J Natl Cancer Inst. 2014 Apr;106(4):dju014. doi: 10.1093/jnci/dju014. Epub 2014 Mar 31. J Natl Cancer Inst. 2014. PMID: 24685931 No abstract available.
• RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

  Tokudome S, Ando R, Ichikawa Y, Ichikawa H, Imaeda N, Goto C, Tokudome Y, Okuyama H. Tokudome S, et al. J Natl Cancer Inst. 2014 Apr;106(4):dju020. doi: 10.1093/jnci/dju020. Epub 2014 Mar 31. J Natl Cancer Inst. 2014. PMID: 24685933 No abstract available.